Cencora, Inc.
COR- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001140859
In the last 90 days, Cencora, Inc. insiders filed 0 open-market purchases and 5 sales; 1,357 institutions reported holding it in 13F filings for Q2 2026, worth $51.8B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:32 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 5, 2025 | Nov 6, 2024 | Nov 2, 2023 | Nov 3, 2022 | Nov 4, 2021 |
| Revenue | $321.3B | $294.0B | $262.2B | $238.6B | $214.0B |
| Cost of revenue | $309.9B | $284.0B | $253.2B | $230.3B | $207.0B |
| Gross profit | $11.5B | $9.91B | $8.96B | $8.30B | $6.94B |
| Operating expenses | $6.99B | – | – | – | – |
| Selling, general and administrative | $6.49B | $5.66B | $5.31B | $4.85B | $3.59B |
| Operating income | $2.63B | $2.18B | $2.34B | $2.37B | $2.35B |
| Income tax | $690.5M | $484.7M | $428.3M | $516.5M | $677.3M |
| Net income | $1.55B | $1.51B | $1.75B | $1.70B | $1.54B |
| EPS, basic | $8.02 | $7.60 | $8.62 | $8.15 | $7.48 |
| EPS, diluted | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 |
| Weighted shares, basic | 193.8M | 198.5M | 202.5M | 208.5M | 205.9M |
| Weighted shares, diluted | 195.2M | 200.3M | 204.6M | 211.2M | 208.5M |
| Margins and growth | |||||
| Gross margin | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% |
| Operating margin | 0.8% | 0.7% | 0.9% | 1.0% | 1.1% |
| Net margin | 0.5% | 0.5% | 0.7% | 0.7% | 0.7% |
| Revenue growth, year over year | +9.3% | +12.1% | +9.9% | +11.5% | +12.7% |
| Net income growth, year over year | +3.0% | −13.5% | +2.7% | +10.3% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 5, 2025 | Nov 6, 2024 | Nov 2, 2023 | Nov 3, 2022 | Nov 4, 2021 |
| Cash and equivalents | $4.36B | $3.13B | $2.59B | $3.39B | $2.55B |
| Accounts receivable | $25.2B | $23.9B | $20.9B | $18.5B | $18.2B |
| Inventory | $20.5B | $19.0B | $17.5B | $15.6B | $15.4B |
| Total current assets | $52.2B | $47.7B | $42.8B | $39.6B | $38.8B |
| Property, plant and equipment | $2.54B | $2.18B | $2.14B | $2.14B | $2.16B |
| Goodwill | $13.7B | $9.32B | $9.57B | $8.50B | $9.03B |
| Intangible assets | $3.77B | $4.00B | $4.43B | $4.33B | $5.26B |
| Total assets | $76.6B | $67.1B | $62.6B | $56.6B | $57.3B |
| Accounts payable | $54.7B | $50.9B | $45.8B | $40.2B | $38.0B |
| Short-term debt | $117.8M | $576.3M | $641.3M | $1.07B | $300.2M |
| Total current liabilities | $57.8B | $54.3B | $48.8B | $43.5B | $41.4B |
| Long-term debt | $7.54B | $3.81B | $4.15B | $4.63B | $6.38B |
| Shareholders' equity | $1.75B | $786.7M | $666.3M | $71.3M | $584.4M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 5, 2025 | Nov 6, 2024 | Nov 2, 2023 | Nov 3, 2022 | Nov 4, 2021 |
| Operating cash flow | $3.88B | $3.48B | $3.91B | $2.70B | $2.67B |
| Capital expenditures | $668.0M | $487.2M | $458.4M | $496.3M | $438.2M |
| Free cash flow | $3.21B | $3.00B | $3.45B | $2.21B | $2.23B |
| Depreciation and amortization | $1.05B | $1.09B | $963.9M | $693.9M | $505.2M |
| Stock-based compensation | $148.0M | $148.0M | $124.6M | $93.4M | $99.6M |
| Dividends paid | $437.1M | $416.2M | $398.8M | $391.7M | $366.6M |
| Share buybacks | $435.5M | $1.49B | $1.18B | $483.7M | $82.2M |
| Investing cash flow | -$4.98B | -$618.1M | -$2.60B | -$368.4M | -$6.14B |
| Financing cash flow | $2.25B | -$2.33B | -$2.22B | -$1.75B | $1.95B |
| Net change in cash | $1.10B | $545.0M | -$840.6M | $523.4M | -$1.53B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Jul 31, 2026 | 190.8M | −1.6% | SEC |
| Apr 30, 2026 | 194.6M | +0.4% | SEC |
| Jan 31, 2026 | 194.5M | +0.3% | SEC |
| Oct 31, 2025 | 194.0M | +0.4% | SEC |
| Jul 31, 2025 | 193.9M | −1.6% | SEC |
| Apr 30, 2025 | 193.8M | −2.8% | SEC |
| Jan 31, 2025 | 193.9M | −2.8% | SEC |
| Oct 31, 2024 | 193.3M | −3.7% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.